FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948946518> ?p ?o ?g. }

• W2948946518 endingPage "70" @default.
• W2948946518 startingPage "49" @default.
• W2948946518 abstract "Introduction: There are appreciable concerns among European health authorities with growing expenditure on cancer medicines and issues of sustainability. The enhanced use of low cost generics could help. Aims: Consequently, there is a need to comprehensively document current and future arrangements regarding the pricing of generic cancer medicines across Europe, and whether these are indication specific, as well as how this translates into actual prices to provide future direction. Methodology: Mixed method approach with qualitative research among senior health authority personnel and their advisers. Quantitative research via health authority databases to ascertain current prices for oral cancer medicines that had lost their patent and the influence of population size and economics on prices. Results: 25 European countries participated. Currently we see (a) variable approaches to the pricing of generic cancer medicines, which will continue; (b) no concerns with substitution for oral generic cancer medicines; (c) substantial price reductions versus originators for generic capecitabine (up to -93.1%), generic imatinib (up to -97.8%) and generic temozolomide (up to -80.7%). Prices for oncology medicines are not indication specific, and are not affected by population size although influenced by pricing approaches. There have also been price increases for some non-patented cancer medicines following manufacturer changes although now stabilising. Conclusion: The considerable price reductions seen for some generics means health authorities should further encourage the use of generic oncology medicines when they become available to fund increased volumes and new valued cancer medicines. Countries are also starting to address price increases for generics following changes in the manufacturer" @default.
• W2948946518 created "2019-06-14" @default.
• W2948946518 creator A5000053019 @default.
• W2948946518 creator A5003628873 @default.
• W2948946518 creator A5004238166 @default.
• W2948946518 creator A5011021646 @default.
• W2948946518 creator A5013215425 @default.
• W2948946518 creator A5014828756 @default.
• W2948946518 creator A5016110170 @default.
• W2948946518 creator A5017307520 @default.
• W2948946518 creator A5017418790 @default.
• W2948946518 creator A5017538000 @default.
• W2948946518 creator A5018276902 @default.
• W2948946518 creator A5018825749 @default.
• W2948946518 creator A5019668892 @default.
• W2948946518 creator A5019711864 @default.
• W2948946518 creator A5027428003 @default.
• W2948946518 creator A5028480298 @default.
• W2948946518 creator A5028684820 @default.
• W2948946518 creator A5029095255 @default.
• W2948946518 creator A5032208400 @default.
• W2948946518 creator A5033055745 @default.
• W2948946518 creator A5033995094 @default.
• W2948946518 creator A5034319085 @default.
• W2948946518 creator A5038508170 @default.
• W2948946518 creator A5042163727 @default.
• W2948946518 creator A5044821212 @default.
• W2948946518 creator A5046286605 @default.
• W2948946518 creator A5047342188 @default.
• W2948946518 creator A5047417686 @default.
• W2948946518 creator A5049591132 @default.
• W2948946518 creator A5050078092 @default.
• W2948946518 creator A5051006112 @default.
• W2948946518 creator A5054138969 @default.
• W2948946518 creator A5055284771 @default.
• W2948946518 creator A5055437052 @default.
• W2948946518 creator A5059464449 @default.
• W2948946518 creator A5060462160 @default.
• W2948946518 creator A5063428562 @default.
• W2948946518 creator A5068909343 @default.
• W2948946518 creator A5070568819 @default.
• W2948946518 creator A5077844105 @default.
• W2948946518 creator A5079498687 @default.
• W2948946518 creator A5081667950 @default.
• W2948946518 creator A5083422193 @default.
• W2948946518 creator A5083548997 @default.
• W2948946518 creator A5084916284 @default.
• W2948946518 creator A5086803562 @default.
• W2948946518 creator A5087211795 @default.
• W2948946518 creator A5089210630 @default.
• W2948946518 date "2019-06-15" @default.
• W2948946518 modified "2023-10-17" @default.
• W2948946518 title "Pricing of oral generic cancer medicines in 25 European countries; findings and implications" @default.
• W2948946518 doi "https://doi.org/10.5639/gabij.2019.0802.007" @default.
• W2948946518 hasPublicationYear "2019" @default.
• W2948946518 type Work @default.
• W2948946518 sameAs 2948946518 @default.
• W2948946518 citedByCount "28" @default.
• W2948946518 countsByYear W29489465182020 @default.
• W2948946518 countsByYear W29489465182021 @default.
• W2948946518 countsByYear W29489465182022 @default.
• W2948946518 countsByYear W29489465182023 @default.
• W2948946518 crossrefType "journal-article" @default.
• W2948946518 hasAuthorship W2948946518A5000053019 @default.
• W2948946518 hasAuthorship W2948946518A5003628873 @default.
• W2948946518 hasAuthorship W2948946518A5004238166 @default.
• W2948946518 hasAuthorship W2948946518A5011021646 @default.
• W2948946518 hasAuthorship W2948946518A5013215425 @default.
• W2948946518 hasAuthorship W2948946518A5014828756 @default.
• W2948946518 hasAuthorship W2948946518A5016110170 @default.
• W2948946518 hasAuthorship W2948946518A5017307520 @default.
• W2948946518 hasAuthorship W2948946518A5017418790 @default.
• W2948946518 hasAuthorship W2948946518A5017538000 @default.
• W2948946518 hasAuthorship W2948946518A5018276902 @default.
• W2948946518 hasAuthorship W2948946518A5018825749 @default.
• W2948946518 hasAuthorship W2948946518A5019668892 @default.
• W2948946518 hasAuthorship W2948946518A5019711864 @default.
• W2948946518 hasAuthorship W2948946518A5027428003 @default.
• W2948946518 hasAuthorship W2948946518A5028480298 @default.
• W2948946518 hasAuthorship W2948946518A5028684820 @default.
• W2948946518 hasAuthorship W2948946518A5029095255 @default.
• W2948946518 hasAuthorship W2948946518A5032208400 @default.
• W2948946518 hasAuthorship W2948946518A5033055745 @default.
• W2948946518 hasAuthorship W2948946518A5033995094 @default.
• W2948946518 hasAuthorship W2948946518A5034319085 @default.
• W2948946518 hasAuthorship W2948946518A5038508170 @default.
• W2948946518 hasAuthorship W2948946518A5042163727 @default.
• W2948946518 hasAuthorship W2948946518A5044821212 @default.
• W2948946518 hasAuthorship W2948946518A5046286605 @default.
• W2948946518 hasAuthorship W2948946518A5047342188 @default.
• W2948946518 hasAuthorship W2948946518A5047417686 @default.
• W2948946518 hasAuthorship W2948946518A5049591132 @default.
• W2948946518 hasAuthorship W2948946518A5050078092 @default.
• W2948946518 hasAuthorship W2948946518A5051006112 @default.
• W2948946518 hasAuthorship W2948946518A5054138969 @default.
• W2948946518 hasAuthorship W2948946518A5055284771 @default.
• W2948946518 hasAuthorship W2948946518A5055437052 @default.
• W2948946518 hasAuthorship W2948946518A5059464449 @default.

• next